FDA Approves Unknown Drug — IMPAX LABS

Impax Laboratories received FDA approval on January 29, 2003, for ANDA 076173, a generic submission specifically cited for patent litigation. This clearance anticipates a U.S. market entry around the first half of the year, positioning Impax to capitalize on the loss of exclusivity for the brand-name product.